Comments for Investors Wondering Why Cel-Sci Has Quietly Amended Previously Filed Paperwork at http://www.biomedreports.com , comment 1 to 10 out of 10 comments http://www.biomedreports.com Wed, 08 Feb 2012 17:52:39 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/2009111117619/investors-wonder-why-cel-sci-has-ammended-previously-filed-paperwork.html#comment-1345 I think that is a promissing company. We have a lot of work here and if the results of phase III of multikind are positves, there will be many people fun because a real nightmare will be finished. It's wortth. Friedrich - friedrich Fri, 13 Nov 2009 00:42:46 +0100 http://www.biomedreports.com/2009111117619/investors-wonder-why-cel-sci-has-ammended-previously-filed-paperwork.html#comment-1338 Regarding dilution: 1. If you look at many of the smaller biotech companies who have given away 90% or more of their profits (on specific compounds having one or more indications) to their big pharma partners and you compare that with Cel-Sci whose so called "diulution" is about raising efficient amounts capital to further their science, you see that they have clearly not "given away the store." To me, anyway, this is prudent. While the math may appear "tricky," it can be done. As it stands now I calculate that outstanding shares could go as high as 250mm -- doesn't include the new money. Please correct me if I am wrong. - RCM Thu, 12 Nov 2009 00:46:49 +0100 http://www.biomedreports.com/2009111117619/investors-wonder-why-cel-sci-has-ammended-previously-filed-paperwork.html#comment-1337 very interesting, i did notice something, they filed the shelf after the law suit was filled for 30 million and 90 million punitive, they said they had plenty of money raised a month ago for there ph 3 trials, plus whats up with this selling warrent's to byron pharma for 22 cents a share 4 days after they became a company, that seems so shady of cvm dealing with a company with no history or any public information, im really surprised the SEC didnt suspend there stock yet for that one. - Daniel furlong Thu, 12 Nov 2009 00:29:21 +0100 http://www.biomedreports.com/2009111117619/investors-wonder-why-cel-sci-has-ammended-previously-filed-paperwork.html#comment-1333 i feel this stock is a success but its a high risk stock cause u dont really no wheather or not this sh*t they say is actually true.. i own it at 44 cents so im holding for now but its been a great buy on the pullbacks it always pops so buy when it dips sell on the pop check the charts - mtino Wed, 11 Nov 2009 15:39:47 +0100 http://www.biomedreports.com/2009111117619/investors-wonder-why-cel-sci-has-ammended-previously-filed-paperwork.html#comment-1332 What disturbs me is what's within the shelf filing. Specifically, the number of shares that might be required to issue to cover outstanding warrants and options (at $0.20/share). From what I can tell, this could double the number of outstanding shares, not including the issues with Iriquois. Add that to the 40 million, and the dilution is more than substantial. - Snr Moment Wed, 11 Nov 2009 12:56:50 +0100 http://www.biomedreports.com/2009111117619/investors-wonder-why-cel-sci-has-ammended-previously-filed-paperwork.html#comment-1331 Hope to see you all at the finish line, I will be the one with the big smile while hopefully cashing in a big check - Don Negri Wed, 11 Nov 2009 12:00:35 +0100 http://www.biomedreports.com/2009111117619/investors-wonder-why-cel-sci-has-ammended-previously-filed-paperwork.html#comment-1330 I hope their a tight squeeze for the naked short. Because someday some big pharma going to buy cvm for the potential pipe lines. - hung Wed, 11 Nov 2009 11:54:05 +0100 http://www.biomedreports.com/2009111117619/investors-wonder-why-cel-sci-has-ammended-previously-filed-paperwork.html#comment-1329 I love this story. Thank for the insight and I been long for 3 months. I hope someday this stock can get the attention from the FDA and also Merk. I think their might be a take over in a near future because this will be a tight squeeze for the short. - hung Wed, 11 Nov 2009 11:50:12 +0100 http://www.biomedreports.com/2009111117619/investors-wonder-why-cel-sci-has-ammended-previously-filed-paperwork.html#comment-1328 This company, along with these crooked reporters, are all con artists,. after months of reading this crap, anyone would have to be a complete sucker to touch this stock - Duaine Swarthout Wed, 11 Nov 2009 10:51:02 +0100 http://www.biomedreports.com/2009111117619/investors-wonder-why-cel-sci-has-ammended-previously-filed-paperwork.html#comment-1327 Hi M.E.Garza, It is great information. Since you refer to Melly Alazraki's story, can you provide more info about her credentials? I hope you can continue to cover CVM when there is any unusual price movements. I also follow HEB and hope you can cover/explain the HEB's situation since you have covered it extensively before. - pcstock_cvm Wed, 11 Nov 2009 10:23:02 +0100